BIOLOGICAL · Unmapped registry intervention
Donislecel (allogeneic islets of Langerhans for transplant)
Find medicine records ·
Find other trials using this name
Clinical trial
Islet Transplantation in Type I Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
NCT03791567
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedIslet Transplantation in Type I Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
Design: EXPANDED_ACCESS · Status: APPROVED FOR MARKETING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
CellTrans Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03791567 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.